Genentech

HERCEPTIN HYLECTA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genentech

Herceptin Hylecta HCPCS:

J9356

HCPCS Code Descriptor:

Injection, trastuzumab, 10 mg and hyaluronidase-oysk

Category:

J Code

Herceptin Hylecta NDCs:

50242-0077-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Herceptin Hylecta CPT Codes:

-96401 - Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Herceptin Hylecta:

HERCEPTIN HYLECTA is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9356 is aligned to the drug HERCEPTIN HYLECTA.

ACCESS PRICING AND MORE BY REGISTERING

J9356 Added Date:

July 1, 2019

J9356 Effective Date:

July 1, 2019

J9356 Termination Date:

HCPCS Active

Herceptin Hylecta billing and coding information can be found through Genentech at the link below:
Herceptin Hylecta patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
HERCEPTIN HYLECTA prescribing information can be found at the link below:
Information regarding HERCEPTIN HYLECTA’s side effects can be found at MedlinePlus